z-logo
Premium
First results of a quantitative study of DNA adducts of melphalan in the rat by isotope dilution mass spectrometry using capillary liquid chromatography coupled to electrospray tandem mass spectrometry
Author(s) -
Van den Driessche Bart,
Esmans Eddy L.,
Van der Linden Annemie,
Van Dongen Walter,
Schaerlaken Evi,
Lemière Filip,
Witters Erwin,
Berneman Zwi
Publication year - 2005
Publication title -
rapid communications in mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.528
H-Index - 136
eISSN - 1097-0231
pISSN - 0951-4198
DOI - 10.1002/rcm.2018
Subject(s) - chemistry , chromatography , isotope dilution , melphalan , mass spectrometry , adduct , tandem mass spectrometry , dna adduct , liquid chromatography–mass spectrometry , transplantation , organic chemistry , medicine , surgery
Rats were intravenously injected with a single high dose (10 mg/kg) of the alkylating agent melphalan in order to study DNA‐adduct formation. Quantitation of a dGuo‐melphalan adduct was done by isotope dilution mass spectrometry using capillary liquid chromatography/mass spectrometry (LC/MS) and [ 15 N 5 ]‐labeled dGuo‐melphalan as internal standard. DNA‐adduct levels were studied in bone marrow, liver and kidney. The instrumental detection limit of the method was determined to be 900 fg (S/N 3, pure standard). These first results clearly show a 10 times higher adduct level in bone marrow compared to kidney and a 6 times higher level compared to liver. More experiments will be necessary to gather more information on the pharmacokinetics of melphalan‐DNA adducts under in vivo conditions. Copyright © 2005 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom